Royce & Associates LP Enanta Pharmaceuticals Inc Transaction History

Royce & Associates LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$41.02 - $58.65 $219,046 - $313,191	-5,340 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$43.76 - $53.11 $25,905 - $31,441	-592 Reduced 9.98%	5,340 $235,000
Q1 2021 May 10, 2021	SELL	$41.69 - $54.95 $197,944 - $260,902	-4,748 Reduced 44.46%	5,932 $293,000
Q4 2020 Feb 08, 2021	BUY	$41.16 - $47.47 $6,997 - $8,069	170 Added 1.62%	10,680 $450,000
Q3 2020 Nov 12, 2020	BUY	$43.36 - $53.53 $1,387 - $1,712	32 Added 0.31%	10,510 $481,000
Q2 2020 Aug 07, 2020	BUY	$46.37 - $57.58 $6,306 - $7,830	136 Added 1.32%	10,478 $526,000
Q1 2020 May 12, 2020	BUY	$40.22 - $62.0 $123,153 - $189,844	3,062 Added 42.06%	10,342 $532,000
Q4 2019 Feb 06, 2020	BUY	$57.95 - $66.61 $208,446 - $239,596	3,597 Added 97.66%	7,280 $450,000
Q3 2019 Nov 13, 2019	BUY	$60.08 - $88.17 $204,452 - $300,042	3,403 Added 1215.36%	3,683 $221,000
Q2 2019 Aug 12, 2019	BUY	$81.3 - $97.35 $406 - $486	5 Added 1.82%	280 $24,000
Q1 2019 May 09, 2019	SELL	$69.08 - $105.66 $898 - $1,373	-13 Reduced 4.51%	275 $26,000
Q4 2018 Feb 11, 2019	BUY	$65.41 - $84.65 $1,635 - $2,116	25 Added 9.51%	288 $20,000
Q3 2018 Nov 13, 2018	BUY	$85.46 - $126.37 $12,049 - $17,818	141 Added 115.57%	263 $22,000
Q2 2018 Aug 09, 2018	BUY	$81.85 - $120.51 $1,391 - $2,048	17 Added 16.19%	122 $14,000
Q1 2018 May 14, 2018	SELL	$57.91 - $92.15 $4,806 - $7,648	-83 Reduced 44.15%	105 $8,000
Q4 2017 Feb 09, 2018	BUY	$45.65 - $59.37 $8,582 - $11,161	188	188 $11,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $116M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.